相关实验视频
Updated: Jun 19, 2025

12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.6K
在CLL中T细胞功能障碍是通过在CLL细胞上表达Siglec-10配体CD24和CD52的介导
Jaco A C van Bruggen1,2, Fleur S Peters1,2, Morris Mes1,2
1Department of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Blood advances
|July 23, 2024
概括
慢性淋巴细胞白血病 (CLL) 通过抑制T细胞功能,损害了仿真抗原受体 (CAR) T细胞疗法. 向CLL细胞表面连接体CD24和CD52可以重振T细胞,改善CLL患者的CART细胞疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 自主T细胞疗法,包括嵌合抗原受体 (CAR) T细胞疗法,在慢性淋巴细胞白血病 (CLL) 中表现出有限的成功.
- T细胞功能障碍是CLL患者的标志性特征,但导致这种情况的特定CLL衍生因素仍然未知.
- 了解CLL介导的T细胞抑制对于改善T细胞治疗结果至关重要.
研究的目的:
- 研究CLL细胞抑制CAR T细胞激活和功能的机制.
- 为了确定负责T细胞功能障碍的特定CLL衍生因素.
- 在CLL的背景下探索重振T细胞的策略.
主要方法:
- 与CLL细胞共同培养T细胞,以评估T细胞激活,细胞因子产生和增殖.
- 利用CD40激活的CLL细胞和直接细胞接触试验来剖析T细胞抑制机制.
- 采用激酶抑制剂 (达沙替尼) 和转录组分析来识别关键信号通路和表面连接体.
- 阻断特定的表面配体 (CD24,CD52),以评估它们在T细胞功能障碍中的作用.
主要成果:
- 在重新刺激后,CLL细胞诱导T细胞激活延迟,细胞因子的产生和扩散受损.
- CD40刺激的CLL细胞和T细胞之间的直接细胞接触是T细胞功能障碍所需的.
- 达沙替尼抑制T细胞功能障碍,而CD40刺激降低了CLL细胞上的Siglec-10配体CD24和CD52的下调.
- 阻断CD24和/或CD52显著降低了与CLL细胞共同培养的CAR T细胞功能障碍.
结论:
- 通过直接细胞接触和特定的表面连接体的机制,CLL细胞积极抑制T细胞功能.
- 在CLL细胞上的CD24和CD52在调解T细胞抑制中发挥着关键作用.
- 向CD24和CD52介导相互作用是一个有前途的治疗策略,以增强CLL中的T细胞功能.
相关概念视频
T Cell Activation and Clonal Selection
694
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
694
Cytotoxic T Cells-mediated Immune Response
883
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
883
T Cell Types and Functions
986
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
986
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K

